Soo-Jin Kim

Technik-/Wissenschafts-/F&E-Leiter bei INOZYME PHARMA, INC.

Vermögen: 2 Mio $ am 30.04.2024

Health Technology

Consumer Services

Aktive Positionen von Soo-Jin Kim

Unternehmen	Position	Beginn	Ende
INOZYME PHARMA, INC.	Technik-/Wissenschafts-/F&E-Leiter	08.03.2022	-

Unternehmen	Position	Beginn	Ende
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Corporate Officer/Principal	-	-
HANMI PHARM. CO., LTD.	Corporate Officer/Principal	-	-
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-	-

Cornell University	Undergraduate Degree
California Institute of Technology	Doctorate Degree

International

Vereinigte Staaten	6
Südkorea	2

Operativ

Corporate Officer/Principal	3
Undergraduate Degree	1
Doctorate Degree	1

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
HANMI PHARM. CO., LTD.	Health Technology
INOZYME PHARMA, INC.	Health Technology

Private Unternehmen	1
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Health Technology

Private Unternehmen

Health Technology